First study ex vivo #NSCLC demonstrating #PDOs are an excellent technology on #subclonal tumor evolution affecting #immuneescape.
t.co/1YUzihcY2H
#nonanimal #alternative #methods #cancer #immunotherapy
First study ex vivo #NSCLC demonstrating #PDOs are an excellent technology on #subclonal tumor evolution affecting #immuneescape.
t.co/1YUzihcY2H
#nonanimal #alternative #methods #cancer #immunotherapy
Had a wonderful time discussing #statistics & #quantitative sciences for #biological #clinical impact w my peers!!
Had a wonderful time discussing #statistics & #quantitative sciences for #biological #clinical impact w my peers!!
Here we come - #music, #food, and GREAT #science 🚀💃 @enar-ibs.bsky.social
Here we come - #music, #food, and GREAT #science 🚀💃 @enar-ibs.bsky.social
Looking forward to further developing this scalable ex vivo technology for rapid #oncology #immunooncology #therapeutic #HNSCC!!!
Check Rose poster #62 tonight to learn more!
Looking forward to further developing this scalable ex vivo technology for rapid #oncology #immunooncology #therapeutic #HNSCC!!!
Check Rose poster #62 tonight to learn more!
🚀Especially important for today’s scientific landscape
🚀Especially important for today’s scientific landscape
scRNAseq revealing endogenous #malignant #transcripts transfer #EV from malignant to nonmalignant cells, toward #GBM cell states + #astroglia cell types!
tinyurl.com/5h2v8tak
scRNAseq revealing endogenous #malignant #transcripts transfer #EV from malignant to nonmalignant cells, toward #GBM cell states + #astroglia cell types!
tinyurl.com/5h2v8tak
#CompIO Webinar Series is here!!! 🎉
Ten courses focusing on advanced methods and clinical utility for #biomarker #development in IO @sitcancer.bsky.social @roswellpark.bsky.social #NCI 👏
✨ FREE registration: tinyurl.com/3863jp9t
Let's spread the word!🚀
#CompIO Webinar Series is here!!! 🎉
Ten courses focusing on advanced methods and clinical utility for #biomarker #development in IO @sitcancer.bsky.social @roswellpark.bsky.social #NCI 👏
✨ FREE registration: tinyurl.com/3863jp9t
Let's spread the word!🚀
www.nature.com/articles/s41...
Interactive portal: archmap.bio#/
Great resource for all researchers in this field!!
www.nature.com/articles/s41...
Interactive portal: archmap.bio#/
Great resource for all researchers in this field!!
#multiomic, #spatial imaging, #pathology, #radiomic technologies enable a deeper understanding of #tumor #biology & #precision #oncology, such as building virtual #digitaltwins to optimize trial design.
www.nature.com/articles/s41...
#multiomic, #spatial imaging, #pathology, #radiomic technologies enable a deeper understanding of #tumor #biology & #precision #oncology, such as building virtual #digitaltwins to optimize trial design.
www.nature.com/articles/s41...
and made to #sungazer concert @ #thunderbird cafe & music hall ☀️ 🎷🎸🥁 which we had missed , for the past three times when they came to #Pittsburgh 🥹
and made to #sungazer concert @ #thunderbird cafe & music hall ☀️ 🎷🎸🥁 which we had missed , for the past three times when they came to #Pittsburgh 🥹
www.cell.com/trends/cance...
www.cell.com/trends/cance...
www.cell.com/cell-stem-ce...
www.cell.com/cell-stem-ce...
We’re spending lots time expanding individual cases, tons of pipetting and limited wells per plate. This is prior to drug screening (which is automated by robots).
🙏 Thanks!!
We’re spending lots time expanding individual cases, tons of pipetting and limited wells per plate. This is prior to drug screening (which is automated by robots).
🙏 Thanks!!
✨317 patients, PET/CT, bulk RNAseq, digitized pathology => #Multimodal #AI outperform traditional methods!
t.co/MfMNwuZaG9
✨317 patients, PET/CT, bulk RNAseq, digitized pathology => #Multimodal #AI outperform traditional methods!
t.co/MfMNwuZaG9
Today we welcome 🌟 Dr. Xianlu (Laura) Peng #UNC_Lineberger to share work decoding #pancreatic cancer #heterogeneity, a aggressive, therapy-resistant cancer🔥!!!#CancerResearch #DataScience
Today we welcome 🌟 Dr. Xianlu (Laura) Peng #UNC_Lineberger to share work decoding #pancreatic cancer #heterogeneity, a aggressive, therapy-resistant cancer🔥!!!#CancerResearch #DataScience
We're hiring. From #tenure to #nontenure track faculty, and #staffscientists @UPMCHillmanCC #datasciences !!
Please RT. Thank you ☺️
We're hiring. From #tenure to #nontenure track faculty, and #staffscientists @UPMCHillmanCC #datasciences !!
Please RT. Thank you ☺️